UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:May 08,
Biocept (NASDAQ:BIOC)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Biocept Charts.
Biocept (NASDAQ:BIOC)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Biocept Charts.

Biocept Inc News

Form 8-K - Current report
Friday 20 October 2023 (6 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Monday 16 October 2023 (6 months ago) • Edgar (US Regulatory)
Enrollment Completed in the Feasibility Phase of the FORESEE Clinical Trial with Biocept’s CNSide™ Assay to Evaluate Patients with Leptomeningeal Metastases
Thursday 21 September 2023 (7 months ago) • Business Wire
Biocept Signs CNSide™ Licensing Agreement with Plus Therapeutics
Friday 8 September 2023 (8 months ago) • Business Wire
Biocept to Participate in the H.C. Wainwright Global Investment Conference
Tuesday 5 September 2023 (8 months ago) • Business Wire
Biocept to Hold Business Update Conference Call on August 30, 2023
Friday 25 August 2023 (8 months ago) • Business Wire
Form 8-K - Current report
Tuesday 22 August 2023 (8 months ago) • Edgar (US Regulatory)
Biocept Reports Second Quarter 2023 Financial Results
Monday 14 August 2023 (8 months ago) • Business Wire
Biocept’s CNSide™ Cerebrospinal Fluid Assay Featured in Two Oral Presentations at the 2023 SNO/ASCO CNS Cancer Conference
Monday 14 August 2023 (8 months ago) • Business Wire
Biocept Announces the Passing of Board Chair M. Faye Wilson
Thursday 13 July 2023 (9 months ago) • Business Wire
Biocept Names Antonino Morales as President and Chief Executive Officer
Tuesday 20 June 2023 (10 months ago) • Business Wire
Biocept to Present at the Maxim Group Virtual Healthcare Conference Hosted by M-Vest on June 20, 2023
Wednesday 14 June 2023 (10 months ago) • Business Wire

More Biocept Inc News Articles